Publications 2021

Bohn SKH, Lie HC, Reinertsen KV, Fossa SD, Haugnes HS, Kiserud CE, Loge JH, Wisloff T, Thorsen L (2021)
Lifestyle among long-term survivors of cancers in young adulthood
Support. Care Cancer, 29 (1), 289-300
DOI 10.1007/s00520-020-05445-6

Briggs AH, Goldstein DA, Kirwin E, Meacock R, Pandya A, Vanness DJ, Wisloff T (2021)
Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19
Health Econ., 30 (3), 699-707
DOI 10.1002/hec.4208

Flem E, Graham J, Yi ZN, Wisloff T, Johnson KD (2021)
Cost and health impact analysis of herpes zoster vaccination in Norway
Expert Rev. Pharmacoecon. Outcomes Res.
DOI 10.1080/14737167.2021.1973893

Pawaskar M, Burgess C, Pillsbury M, Wisloff T, Flem E (2021)
Clinical and economic impact of universal varicella vaccination in Norway: A modeling study
PLoS One, 16 (7), e0254080
DOI 10.1371/journal.pone.0254080

Seland M, Skrede K, Lindemann K, Skaali T, Blomhoff R, Bruheim K, Wisloff T, Thorsen L (2021)
Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer
Acta Obstet. Gynecol. Scand.
DOI 10.1111/aogs.14310

Vervaart M, Strong M, Claxton KP, Welton NJ, Wisloff T, Aas E (2021)
An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial
Med. Decis. Mak., 0272989X211068019
DOI 10.1177/0272989X211068019

Vesela R, Elenjord R, Lehnbom EC, Ofstad EH, Johnsgard T, Zahl-Holmstad B, Risor T, Wisloff T, Roslie L, Filseth OM, Valle PC, Svendsen K, Froyshov HM, Garcia BH (2021)
Integrating the clinical pharmacist into the emergency department interdisciplinary team: a study protocol for a multicentre trial applying a non-randomised stepped-wedge study design
BMJ Open, 11 (11), e049645
DOI 10.1136/bmjopen-2021-049645

Vistad I, Skorstad M, Demmelmaier I, Smastuen MC, Lindemann K, Wisloff T, van de Poll-franse LV, Berntsen S (2021)
Lifestyle and Empowerment Techniques in Survivorship of Gynaecologic Oncology (LETSGO study): a study protocol for a multicentre longitudinal interventional study using mobile health technology and biobanking
BMJ Open, 11 (7), e050930
DOI 10.1136/bmjopen-2021-050930

Watle SV, Naess LM, Tunheim G, Caugant DA, Wisloff T (2021)
Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine
Human Vaccines Immunother., 17 (8), 2777-2787
DOI 10.1080/21645515.2021.1880209

Publications 2020

Haugnes H, Elstrom P, Kacelnik O, Jadczak U, Wisloff T, de Blasio BF (2020)
Financial and temporal costs of patient isolation in Norwegian hospitals
J. Hosp. Infect., 104 (3), 269-275
DOI 10.1016/j.jhin.2019.11.012

Mandrik O, Severens JL, Bardach A, Ghabri S, Hamel C, Mathes T, Vale L, Wisloff T, Goldhaber-Fiebert JD (2020)
Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report
Value Health, 24 (4), 463-472
DOI 10.1016/j.jval.2021.01.002

Melbye H, Helgeland J, Karlstad O, Ariansen I, Langhammer A, Wisloff T, Nafstad P, Nystad W (2020)
Is the Disease Burden from COPD in Norway Falling off? A Study of Time Trends in Three Different Data Sources
Int. J. Chronic Obstr. Pulm. Dis., 15, 323-334
DOI 10.2147/COPD.S235106

Thorsen L, Haugnes HS, Fossa SD, Brydoy M, Tandstad T, Wisloff T, Gjerset GM, Edvardsen E, Larsen KO, Sandset PM, Henriksson CE, Raastad T, Negaard HFS (2020)
Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature
Int. J. Cancer, 147 (11), 3189-3198
DOI 10.1002/ijc.33151

Publications 2019

Bleka O, Wisloff T, Dahlberg PS, Rolseth V, Egeland T (2019)
Advancing estimation of chronological age by utilizing available evidence based on two radiographical methods
Int. J. Legal Med., 133 (1), 217-229
DOI 10.1007/s00414-018-1848-y

Bohn SKH, Fossa SD, Wisloff T, Thorsen L (2019)
Physical activity and associations with treatment-induced adverse effects among prostate cancer patients
Support. Care Cancer, 27 (3), 1001-1011
DOI 10.1007/s00520-018-4389-5

Bohn SKH, Thorsen L, Kiserud CE, Fossa SD, Li HC, Loge JH, Wisloff T, Haugnes HS, Reinertsen KV (2019)
Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
Acta Oncol., 58 (5), 753-762
DOI 10.1080/0284186X.2018.1557344

Evensen S, Wisloff T, Lystad JU, Bull H, Martinsen EW, Ueland T, Falkum E (2019)
Exploring the potential cost-effectiveness of a vocational rehabilitation program for individuals with schizophrenia in a high-income welfare society
BMC Psychiatry, 19, 140
DOI 10.1186/s12888-019-2130-7

Gjerset GM, Kiserud CE, Loge JH, Fossa SD, Wisloff T, Gudbergsson SB, Oldervoll LM, Thorsen L (2019)
Changes in fatigue, health-related quality of life and physical activity after a one-week educational program for cancer survivors
Acta Oncol., 58 (5), 682-689
DOI 10.1080/0284186X.2018.1562210

Haugnes H, Flem E, Wisloff T (2019)
Healthcare costs associated with varicella and herpes zoster in Norway
Vaccine, 37 (29), 3779-3784
DOI 10.1016/j.vaccine.2019.05.063

Jelin E, Wisloff T, Jorstad OK, Heiberg T, Moe MC (2019)
Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective study
BMJ Open Ophthalmol., 4 (1), e000353
DOI 10.1136/bmjophth-2019-000353

Jelin E, Wisloff T, Moe MC, Heiberg T (2019)
Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population
Health Qual. Life Outcomes, 17 (1), 140
DOI 10.1186/s12955-019-1203-0

Sahba M, Krog AH, Pettersen EM, Wisloff T, Rogne KG, Sundhagen JO, Kazmi SSH (2019)
Cost comparison analysis of laparoscopic versus open aortobifemoral bypass surgery: a randomized controlled trial
Open Access J. Clin. Trials, 11, 11-18
DOI 10.2147/OAJCT.S192552

Wisloff T, Mundal LJ, Retterstol K, Igland J, Kristiansen IS (2019)
Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects
Atherosclerosis, 287, 140-146
DOI 10.1016/j.atherosclerosis.2019.06.900

Publications 2018

Andreasen C, Solberg LB, Basso T, Borgen TT, Dahl C, Wisloff T, Hagen G, Apalset EM, Gjertsen JE, Figved W, Hubschle LM, Stutzer JM, Elvenes J, Joakimsen RM, Syversen U, Eriksen EF, Nordsletten L, Frihagen F, Omsland TK, Bjornerem A (2018)
Effect of a Fracture Liaison Service on the Rate of Subsequent Fracture Among Patients With a Fragility Fracture in the Norwegian Capture the Fracture Initiative (NoFRACT) A Trial Protocol
JAMA Netw. Open, 1 (8), e185701
DOI 10.1001/jamanetworkopen.2018.5701

Jelin E, Wisloff T, Moe MC, Heiberg T (2018)
Development and testing of a patient-derived questionnaire for treatment of neovascular age-related macular degeneration: dimensions of importance in treatment of neovascular age-related macular degeneration
Acta Ophthalmol., 96 (8), 804-811
DOI 10.1111/aos.13847

Korman M, Wisloff T (2018)
Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting
EUR. HEART J.-CARDIOVASC. PHARMACOTHER., 4 (1), 15-22
DOI 10.1093/ehjcvp/pvx010

Korman MJ, Retterstol K, Kristiansen IS, Wisloff T (2018)
Are PCSK9 Inhibitors Cost Effective?
Pharmacoeconomics, 36 (9), 1031-1041
DOI 10.1007/s40273-018-0671-0

Lousdal ML, Moller MH, Kristiansen IS, Kalager M, Wisloff T, Stovring H (2018)
The Screening Illustrator: separating the effects of lead-time and overdiagnosis in mammography screening
Eur. J. Public Health, 28 (6), 1138-1142
DOI 10.1093/eurpub/cky085

Mundal LJ, Igland J, Veierod MB, Holven KB, Ose L, Selmer RM, Wisloff T, Kristiansen IS, Tell GS, Leren TP, Retterstol K (2018)
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
Heart, 104 (19), 1600-+
DOI 10.1136/heartjnl-2017-312706

Wisloff T, White R, Dalgard O, Amundsen EJ, Meijerink H, Klovstad H (2018)
Feasibility of reaching world health organization targets for hepatitis C and the cost-effectiveness of alternative strategies
J. Viral Hepatitis, 25 (9), 1066-1077
DOI 10.1111/jvh.12904

Wisloff T, White R, Dalgard O, Amundsen EJ, Meijerink H, Lovlie AL, Klovstad H (2018)
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Pharmacoeconomics, 36 (5), 591-601
DOI 10.1007/s40273-017-0604-3

Publications 2017

Gjerset GM, Loge JH, Kiserud CE, Fossa SD, Gudbergsson SB, Oldervoll LM, Wisloff T, Thorsen L (2017)
Perceived needs for different components in a rehabilitation program among cancer survivors with chronic fatigue compared to survivors without chronic fatigue
Acta Oncol., 56 (2), 245-253
DOI 10.1080/0284186X.2016.1266091

Krog AH, Sahba M, Pettersen EM, Wisloff T, Sundhagen JO, Kazmi SSH (2017)
Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery
Vasc. Health Risk Manag., 13, 217-224
DOI 10.2147/VHRM.S138516

Lie I, Danielsen SO, Tonnessen T, Solheim S, Leegaard M, Sandvik L, Wisloff T, Vangen J, Rosstad TH, Moons P (2017)
Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial
Trials, 18, 246
DOI 10.1186/s13063-017-1971-y

Wisloff T (2017)
New Norwegian threshold for the value of a good year of life?
Tidsskr. Nor. Laegeforen., 137 (7-8), 518
DOI 10.4045/tidsskr.17.0137

Publications 2016

Evensen S, Wisloff T, Lystad JU, Bull H, Ueland T, Falkum E (2016)
Prevalence, Employment Rate, and Cost of Schizophrenia in a High-Income Welfare Society: A Population-Based Study Using Comprehensive Health and Welfare Registers
Schizophr. Bull., 42 (2), 476-483
DOI 10.1093/schbul/sbv141

Hagen G, Wisloff T, Kristiansen IS (2016)
The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention-the impact of cardiovascular effects
Osteoporosis Int., 27 (6), 2089-2098
DOI 10.1007/s00198-016-3495-9

Meyer K, Wahl AK, Bjork IT, Wisloff T, Hartmann A, Andersen MH (2016)
Long-term, self-reported health outcomes in kidney donors
BMC Nephrol., 17, 8
DOI 10.1186/s12882-016-0221-y

Werner EL, Storheim K, Lochting I, Wisloff T, Grotle M (2016)
Cognitive Patient Education for Low Back Pain in Primary Care: A Cluster Randomized Controlled Trial and Cost-Effectiveness Analysis
SPINE, 41 (6), 455-462
DOI 10.1097/BRS.0000000000001268

Wisloff T, Atar D (2016)
Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
Eur. Heart J., 2 (1), 52-57
DOI 10.1093/ehjqcco/qcv023

Publications 2015

Wisloff T (2015)
Prioritization Criteria in Health Care
Tidsskr. Nor. Laegeforen., 135 (15), 1373-1375
DOI 10.4045/tidsskr.15.0228

Wisloff T, Robberstad B (2015)
Markov - modeling
Tidsskr. Nor. Laegeforen., 135 (16), 1432

Publications 2014

Wisloff T, Hagen G, Hamidi V, Movik E, Klemp M, Olsen JA (2014)
Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010
Pharmacoeconomics, 32 (4), 367-375
DOI 10.1007/s40273-014-0136-z

Wisloff T, Hagen G, Klemp M (2014)
Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
Pharmacoeconomics, 32 (6), 601-612
DOI 10.1007/s40273-014-0152-z

Publications 2013

Boberg KM, Wisloff T, Kjollesdal KS, Stovring H, Kristiansen IS (2013)
Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid
Aliment. Pharmacol. Ther., 38 (7), 794-803
DOI 10.1111/apt.12435

Stovring H, Harmsen CG, Wisloff T, Jarbol DE, Nexoe J, Nielsen JB, Kristiansen IS (2013)
A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality
Eur. J. Prev. Cardiol., 20 (5), 827-836
DOI 10.1177/2047487312445425

Wisloff T, Atar D, Kristiansen IS (2013)
Cost Effectiveness of Drug-Eluting Stents as Compared With Bare Metal Stents in Patients With Coronary Artery Disease
Am. J. Ther., 20 (6), 596-601
DOI 10.1097/MJT.0b013e3182211a01

Publications 2012

Wien TN, Pike E, Wisloff T, Staff A, Smeland S, Klemp M (2012)
Cancer risk with folic acid supplements: a systematic review and meta-analysis
BMJ Open, 2 (1), e000653
DOI 10.1136/bmjopen-2011-000653

Wisloff T, Selmer RM, Halvorsen S, Fretheim A, Norheim OF, Kristiansen IS (2012)
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
BMC Cardiovasc. Disord., 12, 26
DOI 10.1186/1471-2261-12-26

Wisloff T, Aalen OO, Kristiansen IS (2012)
Regarding adequate methods for comparison of effect measures reply
J. Clin. Epidemiol., 65 (4), 462-463
DOI 10.1016/j.jclinepi.2011.10.005

Publications 2011

Norheim OF, Gjelsvik B, Klemsdal TO, Madsen S, Meland E, Narvesen S, Negard A, Njolstad I, Tonstad S, Ulvin F, Wisloff T (2011)
Norway's new principles for primary prevention of cardiovascular disease: age differentiated risk thresholds
BMJ-British Medical Journal, 343, d3626
DOI 10.1136/bmj.d3626

Wisloff T, Aalen OO, Kristiansen IS (2011)
Considerable variation in NNT - A study based on Monte Carlo simulations
J. Clin. Epidemiol., 64 (4), 444-450
DOI 10.1016/j.jclinepi.2010.04.025

Publications 2008

Berntsen S, Wisloff T, Nafstad P, Nystad W (2008)
Lung Function Increases With Increasing Level of Physical Activity in School Children
Pediatr. Exerc. Sci., 20 (4), 402-410
DOI 10.1123/pes.20.4.402

Publications 2006

Bell RF, Wisloff T, Eccleston C, Kalso E (2006)
Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review
Br. J. Cancer, 94 (11), 1559-1567
DOI 10.1038/sj.bjc.6603162

Wisloff T, Abrahamsen TG, Bergsaker MAR, Lovoll O, Moller P, Pedersen MK, Kristiansen IS (2006)
Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program
Vaccine, 24 (29-30), 5690-5699
DOI 10.1016/j.vaccine.2006.04.042

Publications 2004

Kløw NE, Rotevatn S, Steigen T, Vatne K, Wisløff T, Kristensen IS, Norderhaug I (2004)
Forebygging av restenose i hjertets kransårer
In Rapport, Kunnskapssenteret, Oslo, nr 8/2004, 143 s.
BIBSYS 050087517, ISBN 82-8121-008-7

Nafstad P, Haheim LL, Wisloff T, Gram F, Oftedal B, Holme I, Hjermann I, Leren P (2004)
Urban air pollution and mortality in a cohort of Norwegian men
Environ. Health Perspect., 112 (5), 610-615
DOI 10.1289/ehp.6684